Molecure SA, former OncoArendi Therapeutics (OAT), is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases. OncoArendi’s business model is strictly focused on drug discovery and development, with its core strength in high quality medicinal chemistry and preclinical biology, enhanced by scientific collaborations with the key opinion leaders in specific disease areas and prudent use of CROs.
Headquarters
Zwirki i Wigury 101
Warsaw; Mazowieckie;
Postal Code: 02-089
Contact Details: Purchase the Molecure S. A. report to view the information.
Website: http://www.molecure.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service